Patents by Inventor Stéphanie Blum

Stéphanie Blum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6887465
    Abstract: Novel microorganisms of the family Lactobacillaceae and pharmaceutical compositions, food and methods of using same are provided. The microorganisms have the ability of preventing colonization of the intestine with pathogenic bacteria causing diarrhea and of preventing infection of intestinal epithelial cells by rotaviruses. The microorganisms can be used for the preparation of an ingestable support and to compositions containing same.
    Type: Grant
    Filed: March 2, 2000
    Date of Patent: May 3, 2005
    Assignee: Nestec S.A.
    Inventors: Roberto Reniero, Harald Bruessow, Florence Rochat, Thierry Von Der Weid, Stephanie Blum-Speriesen, Jean-Richard Neeser, Alain Servin
  • Publication number: 20040115773
    Abstract: The present invention pertains to a novel gene of Bifidobacteria and to the polypeptides encoded thereby. In particular, the present invention pertains to a gene belonging to the Serpin superfamily and its use in the production of bacterial Serpins. Also provides are vectors host cells, and methods for producing bacterial Serpin polynucleotides and/or polypeptides.
    Type: Application
    Filed: February 3, 2004
    Publication date: June 17, 2004
    Inventors: Fabrizio Arigoni, Stephanie Blum, Michele Delley, Mark Allan Schell, Eduardo Schiffrin
  • Patent number: 6399381
    Abstract: Human epithelial colon immortalized cell line, which does not express tumour markers, which expresses metabolic markers specific for the non-immortalized human epithelial cells and metabolic differentiation markers specific for the non-immortalized epithelial cells of the human colon, and which is capable of adhering in vitro to the strain of lactic acid bacterium CNCM-1225. Serum-free culture medium characterized in that it comprises trace elements, vitamins consisting of vitamin C and retinoic acid, and hormones consisting of triiodothyronine, dexamethasone, hydrocortisone, bovine pituary gland extract, insulin, EGF and transferrin. Process for the immortalization of epithelial cells of the human colon, in which a culture of primary epithelial cells derived from the human colon is prepared, the culture is infected with a recombinant virus, the immortalized cells are cultured in the serum-free culture medium according to the invention.
    Type: Grant
    Filed: June 14, 2000
    Date of Patent: June 4, 2002
    Assignee: Nestac S.A.
    Inventors: Stéphanie Blum, Andrea Pfeifer, Yvonne Tromvoukis
  • Patent number: 6395542
    Abstract: Human epithelial colon immortalized cell line, which does not express tumour markers, which expresses metabolic markers specific for the non-immortalized human epithelial cells and metabolic differentiation markers specific for the non-immortalized epithelial cells of the human colon, and which is capable of adhering in vitro to the strain of lactic acid bacterium CNCM-1225. Serum-free culture medium characterized in that it comprises trace elements, vitamins consisting of vitamin C and retinoic acid, and hormones consisting of triiodothyronine, dexamethasone, hydrocortisone, bovine pituary gland extract, insulin, EGF and transferrin. Process for the immortalization of epithelial cells of the human colon, in which a culture of primary epithelial cells derived from the human colon is prepared, the culture is infected with a recombinant virus, the immortalized cells are cultured in the serum-free culture medium according to the invention.
    Type: Grant
    Filed: June 14, 2000
    Date of Patent: May 28, 2002
    Assignee: Nestec S.A.
    Inventors: Stéphanie Blum, Andrea Pfeifer, Yvonne Tromvoukis
  • Patent number: 6194203
    Abstract: Immortalized adult human colon epithelial cell line, which does not express tumour markers, which expresses metabolic markers specific for the non-immortalized human epithelial cells and metabolic differentiation markers specific for the non-immortalized epithelial cells of the human colon, and which is capable of adhering in vitro to the strain of lactic acid bacterium CNCM-1225. Serum-free culture medium characterized in that it comprises trace elements, vitamins consisting of vitamin C and retinoic acid, and hormones consisting of triiodothyronine, dexamethasone, hydrocortisone, bovine pituary gland extract, insulin, EGF and transferrin. Process for the immortalization of epithelial cells of the human colon, in which a culture of primary epithelial cells derived from the human colon is prepared, the culture is infected with a recombinant virus, the immortalized cells are cultured in the serum-free culture medium according to the invention.
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: February 27, 2001
    Assignee: Nestec S.A.
    Inventors: Stéphanie Blum, Andrea Pfeifer, Yvonne Tromvoukis